Paediatric Parapneumonic Empyema in Germany First Results on the Therapeutic Management from a Nationwide Surveillance Study
, Hagemann C1
, Keller S1
, Schoen C2
, van der Linden M3
, Rose MA4
, Liese J1
Paediatric Infectious Diseases and Immunology, University Children’s Hospital Würzburg, Germany.
Institute of Hygiene and Microbiology, University of Würzburg, Germany.
National Reference Center for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, Germany.
Children’s Hospital, University of Frankfurt, Germany.
•Parapneumonic effusions and pleural empyema (PPE/PE) in children are rare complications of mainly bacterial pneumonias.
and Staphylococcus aureus
are the most important pathogens
•There are no systematically evaluated data on the therapeutic management of this rare disease in Germany.
•Evaluation of the current therapeutic practice in PPE/PE
•Assessment of bacteriological pathogens in children with PPE/PE (see Poster No. 89).
•Evaluation of the outcome and persistent sequelae
•Identification of risk factors for a severe course and surgical procedures